NCT00189722View on ClinicalTrials.gov

Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma

PHASE2CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

Not specified

Primary Completion Date

July 31, 2005

Study Completion Date

July 31, 2005

Conditions
Asthma, BronchialBronchial Asthma
Interventions
DRUG

Tacrolimus

Trial Locations (28)

10365

Berlin

10717

Berlin

14050

Berlin

15562

Rudersdorf

20535

Hamburg

25742

Krhanice

30159

Hanover

49044

Dnipro

65187

Wiesbaden

65691

Brno

69035

Zaporizhzhya

77520

Olomouc

78752

Šumperk

80802

München

94469

Deggendort

143420

Moscow

194291

Saint Petersburg

197022

Saint Petersburg

197291

Saint Petersburg

214018

Smolensk

620142

Yekaterinburg

15-025

Bialystok

31-133

Krakow

90-153

Lodz

20-718

Lublin

33-100

Tarnów

50-434

Wroclaw

03680

Kiev

Sponsors
All Listed Sponsors
collaborator

Astellas Pharma Europe B.V.

INDUSTRY

lead

Astellas Pharma Inc

INDUSTRY